Source: ERS webinar 2021: COVID-19 vaccination and more
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yorgancioglu (Konak, Turkey), J. Chorostowska (Warsaw, Poland), T. Welte (Hannover, Germany), M. Akova (Ankara, Turkey), A. Sayiner (Izmir, Turkey). COVID-19 vaccination and more. ERS webinar 2021: COVID-19 vaccination and more

Member's Comments

No comment yet.

Related content which might interest you: Understanding new vaccines for SARS-CoV-2 and their regulation Source: ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation Year: 2021 Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018 Ebola: progress with vaccines Source: International Congress 2015 – Pandemics and emerging infections Year: 2015 New treatments for RSV and other viruses, including update on vaccines Source: ERS Courses: Paediatric respiratory infections Year: 2019 Influenza and pneumococcal vaccination Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017 Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014 New Influenza vaccines Source: Virtual Congress 2021 – Vaccination and infections Year: 2021 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 The influenza pandemic: 1918 compared to 2005 Source: Annual Congress 2005 - New developments in infectious disease Year: 2005 Searching for a pandemic influenza vaccine Source: International Congress 2014 – Virulent topics in respiratory infections Year: 2014 Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021 The relation of people to vaccination against an influenza virus Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Influenza and pneumococcal immunization initiates work Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001 Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus. Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Rhinovirus vaccination: the case against Source: Eur Respir J 2011; 37: 5-7 Year: 2011 Medical staff attitude to vaccination against an influenza virus Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013